Current with legislation from 2024 Fiscal and Special Sessions.
Section 20-7-611 - Unlawful acts and penalties(a)(1) It is unlawful for a dispenser to purposely fail to submit prescription monitoring information as required under this subchapter.(2) A violation of subdivision (a)(1) of this section is a Class B misdemeanor.(b)(1) It is unlawful for a dispenser to purposely submit fraudulent prescription information.(2) A violation of subdivision (b)(1) of this section is a Class D felony.(c)(1) It is unlawful for a person authorized to receive prescription monitoring information to purposely disclose the information in violation of this subchapter.(2) A violation of subdivision (c)(1) of this section is a Class C felony.(d)(1) It is unlawful for a person authorized to receive prescription drug monitoring program information to use such information in a manner or for a purpose in violation of this subchapter.(2) A violation of subdivision (d)(1) of this section is a Class C felony.(e)(1) It is unlawful for a person to knowingly obtain, use, or disclose or attempt to obtain, use, or disclose information by fraud or deceit from the Prescription Drug Monitoring Program or from a person authorized to receive information from the Prescription Drug Monitoring Program under this subchapter.(2) A violation of subdivision (e)(1) of this section is a Class C felony.(f) In addition to the criminal penalties provided in this section, a dispenser or practitioner who uses or discloses confidential information received from the Prescription Drug Monitoring Program in a manner or for a purpose in violation of this subchapter may be subject to disciplinary action by the dispenser's or practitioner's licensing board.(g) In addition to the criminal penalties provided in this section, a law enforcement officer who uses or discloses confidential information received from the Prescription Drug Monitoring Program in a manner or for a purpose in violation of this subchapter may be subject to disciplinary action by the law enforcement officer's agency or department.(h) This subchapter does not limit a person whose privacy has been compromised unlawfully under this section from bringing a civil action to address the breach of privacy or to recover all damages to which the person may be entitled per violation, including attorney's fees and costs.(i) A practitioner who purposely fails to access the Prescription Drug Monitoring Program as required by § 20-7-604(d) is subject to disciplinary action by the licensing board of the practitioner.Amended by Act 2017, No. 820,§ 3, eff. 8/1/2017.